Sunitinib is used as a targeted therapy and a receptor protein-tyrosine kinase inhibitor for advanced renal cell cancer and gastrointensinal stromal tumor (GIST). Sunitinib is marketed under the name Sutent. The drug may also be used in combination with other chemotherapy drugs or for the treatment of other cancers.
More information
More information
Related categories 1
Sites 2
Official site and information about using the drug in treatment for advanced renal cell carcinoma and gastrointestinal stromal tumor (GIST).
Description of targeted therapy drug includes indications for therapy and links.
Description of targeted therapy drug includes indications for therapy and links.
Official site and information about using the drug in treatment for advanced renal cell carcinoma and gastrointestinal stromal tumor (GIST).
